(VIANEWS) – Shares of 10x Genomics (NASDAQ: TXG) dropped 8.22% to $46.62 at 11:53 EST on Thursday, after five consecutive sessions in a row of losses. NASDAQ is jumping 0.91% to $12,602.70, after two consecutive sessions in a row of losses. This seems, up to now, a somewhat bullish trend exchanging session today.

10x Genomics’s last close was $50.79, 75.7% under its 52-week high of $208.99.


Today’s last reported volume for 10x Genomics is 583506 which is 52.28% below its average volume of 1222860.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the present quarter and 33.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.


10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.20%, a negative 1.54%, and a positive 4.62%, respectively.

10x Genomics’s highest amplitude of average volatility was 3.48% (last week), 4.27% (last month), and 4.62% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be overbought (>=80).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $46.62 at 11:53 EST, way below its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s value is way under its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.

More news about 10x Genomics (TXG).


Please enter your comment!
Please enter your name here